On the recordMarch 29, 2023
That was the questionable pay to play where they would pay to present themselves before the FDA advisory committees.
Source
congress.govEditor's note · Context
Manchin criticizes the practice of paying to present at FDA meetings.
Share & report
More from Joe Manchin
Dec 18, 2024
Let me just say that I think what happened is we have a bill that is hard to vote against. It really is. And I understand why there were 73 Senators who voted for it. Senator Cruz has had this and worked diligently for many years on this…
Dec 11, 2024
Madam President, I ask unanimous consent that the Senate proceed to the immediate consideration of H.R. 5646, which was received from the House and is at the desk. The PRESIDING OFFICER. The clerk will report the bill by title. The…
Dec 11, 2024
I ask unanimous consent that the bill be considered read a third time and passed and that the motion to reconsider be considered made and laid upon the table. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (H.R. 5301)…
Dec 11, 2024
Madam President, if there is no further business to come before the Senate, I ask that it stand adjourned under the previous order. There being no objection, the Senate, at 7:17 p.m., adjourned until Thursday, December 12, 2024, at 10 a.m…
Other voices in this conversation
